Advanced Cardio (GW-0742)

ACTIVE HALF-LIFE 20-24 hours
CLASSIFICATION PPAR-beta agonist
DOSAGE 20 mg/day
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Euro-Pharmacies - US
LAB TEST See Document
WAREHOUSE USA Warehouse 3
SUBSTANCE GW-0742

Unraveling the mystery around GW0742, this remarkable compound is often mistaken for a new SARM, but it actually belongs to the category of PPAR delta agonists, much like Cardarine. Interestingly, it is believed that GW0742 was developed to extend GlaxoSmithKline's patent on Cardarine, as the chemical structure of GW0742 reveals only a slight variation of a single atom from Cardarine, suggesting they may share similar effects.

GW0742 operates effectively as a PPAR delta agonist, primarily aimed at converting fat into energy while boosting muscle oxidative capacity. This makes GW0742 an exciting option for athletes looking to enhance their endurance levels. However, it is important to note that, as of now, there are no studies, including animal trials, that thoroughly investigate the impact of GW0742 on endurance.

Research has shown that GW0742 enhances insulin sensitivity, which may help lower the risk of developing type II diabetes, based on studies conducted on rats. Unfortunately, human trials are yet to be initiated for this novel compound, but given its promising benefits, we anticipate further research in the near future.